LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Kezdőlap・Részvénylista・Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Inc

Lezárt

3.5 -2.51

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

3.46

Maximum

3.67

Fő mutatók
By Trading Economics
Bevétel	-136K -35M
Egy részvényre jutó nyereség	-0.503
Munkavállalók	106
EBITDA	-619K -38M

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	+94.44% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. aug. 4.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	-34M 261M
Előző nyitás	6.01
Előző zárás	3.5

Zentalis Pharmaceuticals Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. jún. 10. 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

The iShares Global Infrastructure ETF is lower in after-market hours, influenced by declines in the Canadian market and rising geopolitical tensions.

2026. jún. 10. 23:56 UTC

JD.Com Inc. is trading roughly flat in after-market hours, with performance reflecting a position about 6.33% below its 20-day moving average.

2026. jún. 10. 23:56 UTC

Cisco Systems shares are lower in after-market trading, continuing a trend of three consecutive sessions finishing down. No specific news was identified for the decline.

2026. jún. 10. 23:53 UTC

News

Correlated Moves

Silver/GBP declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also trades lower.

2026. jún. 10. 23:52 UTC

News

Correlated Moves

SPDR Gold Shares are trading lower after reports of explosions in Tehran raise regional stability concerns, prompting investors to seek safe-haven assets.

2026. jún. 10. 23:52 UTC

News

Correlated Moves

Silver/JPY is trading lower as geopolitical tensions in Iran affect investor sentiment and contribute to fluctuations in precious metals. Gold's decline also impacts silver prices.

2026. jún. 10. 23:52 UTC

News

Correlated Moves

Silver prices are lower amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes.

2026. jún. 10. 23:52 UTC

News

Correlated Moves

Silver/CAD declines amid geopolitical tensions in Iran and rising U.S. inflation, reversing a trend of higher daily closes. Gold also trades lower in correlation.

2026. jún. 10. 23:52 UTC

News

Correlated Moves

Silver declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also shows a downward movement.

2026. jún. 10. 23:51 UTC

Amgen Inc. shares declined in after-market trading, continuing a trend of lower daily closes amid rising Treasury yields and weakness in technology stocks.

2026. jún. 10. 23:51 UTC

Social Media

CSX shares advance in after-market trading, driven by recognition of the Howard Street Tunnel Project by RTS Magazine as a top 2026 project.

2026. jún. 10. 23:51 UTC

Fastenal shares are higher in after-market trading, supported by a rise in the Trading Companies & Distributors sub-sector. The stock remains above its 20-day moving average.

2026. jún. 10. 23:51 UTC

Global equity markets decline amid U.S.-Iran tensions and mixed economic data, as inflation concerns rise ahead of key Federal Reserve decisions.

2026. jún. 10. 23:51 UTC

Asia equity markets decline amid U.S.-Iran tensions and mixed economic signals from China, while investors brace for U.S. inflation data impacting Federal Reserve policy.

2026. jún. 10. 23:51 UTC

European equity markets decline amid U.S.-Iran tensions and weak UK housing data, while investors await ECB rate hike and U.S. inflation figures.

2026. jún. 10. 23:51 UTC

US equity markets decline amid rising geopolitical tensions with Iran and persistent inflation concerns ahead of key economic data.

2026. jún. 10. 23:51 UTC

UK House Price Balance Data Shows Deeper Decline at -0.35%, Heightening Economic Concerns Amid Global Uncertainties

2026. jún. 10. 23:51 UTC

South Korea's unemployment rate holds steady at 2.8% amid job losses and global economic uncertainties, raising concerns for investor confidence.

2026. jún. 10. 23:51 UTC

Brazil's Inflation Rate Expected to Rise to 4.66% YoY in May Amid Global Price Pressures and Geopolitical Tensions

2026. jún. 10. 23:51 UTC

Brazil's Business Confidence Index set for June 12 release shows cautious market sentiment amid ongoing economic uncertainties.

2026. jún. 10. 23:51 UTC

Check Point Software Technologies is lower in after-market hours amid broader market weakness and declines in the Systems Software sector. No specific company news was identified.

2026. jún. 10. 23:51 UTC

News

ETF Constituents

The Vanguard Growth ETF is lower in after-market hours, impacted by declines in major holdings like Amazon and AMD amid broader geopolitical tensions.

2026. jún. 10. 23:51 UTC

abrdn Physical Palladium Shares ETF is lower in after-market trading amid declining global equity markets due to rising tensions between the U.S. and Iran.

2026. jún. 10. 23:51 UTC

Intuitive Surgical Inc shares are lower in after-market trading amid broader market declines and no specific company news identified. Concerns over geopolitical issues persist.

2026. jún. 10. 23:51 UTC

American Airlines Group Inc shares are lower in after-market hours, reflecting broader market weakness amid rising bond yields and recent economic data.

2026. jún. 10. 23:51 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, reflecting broader market declines and notable drops in major technology stocks amid geopolitical concerns.

2026. jún. 10. 23:51 UTC

Correlated Moves

Alphabet Inc. shares are lower in after-market trading, reflecting broader market weakness amid geopolitical concerns and profit-taking in major tech stocks.

2026. jún. 10. 23:46 UTC

Take-Two Interactive Software Inc shares are lower in after-market hours, continuing a trend of declining performance without any specific news to explain the movement.

2026. jún. 10. 23:46 UTC

Workday Inc. shares are lower in after-market trading, continuing a trend of five consecutive sessions of declines amid no specific news to explain the movement.

2026. jún. 10. 23:46 UTC

News

Starbucks Corp reported strong Q2 results and positive FY26 guidance. Shares are modestly higher in after-market trading, recovering from an earlier dip.

Társak összehasonlítása

Árváltozás

Zentalis Pharmaceuticals Inc Előrejelzés

Célár

By TipRanks

94.44% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 7 USD 94.44%

Magas 10 USD

Alacsony 4 USD

7 Wall Street elemző 12 hónapos célárain alapulva a(z)Zentalis Pharmaceuticals Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

7 ratings

Vétel

Tartás

Eladás

7 Wall Street elemző célárain alapulva a(z)Zentalis Pharmaceuticals Inc termékhez az elmúlt 3 hónapban.

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.